Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.

Ashad-Bishop K, Garikapati K, Lindley LE, Jorda M, Briegel KJ.

Biochem Biophys Res Commun. 2018 Nov 30. pii: S0006-291X(18)32590-7. doi: 10.1016/j.bbrc.2018.11.155. [Epub ahead of print]

PMID:
30509497
2.

Adult Renal Neoplasms: Cytology, Immunohistochemistry, and Cytogenetic Characteristics.

Velez-Torres J, Guido LP, Jorda M.

Surg Pathol Clin. 2018 Sep;11(3):611-631. doi: 10.1016/j.path.2018.06.003. Review.

PMID:
30190144
3.

Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.

Birnbaum MD, Zhao N, Moorthy BT, Patel DM, Kryvenko ON, Heidman L, Kumar A, Morgan WM, Ban Y, Reis IM, Chen X, Gonzalgo ML, Jorda M, Burnstein KL, Zhang F.

Oncogene. 2018 Sep 3. doi: 10.1038/s41388-018-0462-2. [Epub ahead of print]

PMID:
30177837
4.

Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation team.

Vosoughi A, Smith PT, Zeitouni JA, Sodeman MSc GM, Jorda M, Gomez-Fernandez C, Garcia-Buitrago M, Ordobazari A, Petito CK, Chapman JR, Campuzano-Zuluaga G, Rosenberg AE, Kryvenko ON.

Hum Pathol. 2018 Aug;78:144-150. doi: 10.1016/j.humpath.2018.04.012. Epub 2018 May 1.

PMID:
29723604
5.

Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications.

Buj R, Mallona I, Díez-Villanueva A, Zafon C, Mate JL, Roca M, Puig-Domingo M, Reverter JL, Mauricio D, Peinado MA, Jordà M.

Thyroid. 2018 May;28(5):601-612. doi: 10.1089/thy.2017.0501.

PMID:
29635968
6.

Adrenal Oncocytic Neoplasm with Paradoxical Loss of Important Mitochondrial Steroidogenic Protein: The 18 kDA Translocator Protein.

Ruiz-Cordero R, Gupta A, Jayakumar AR, Ciancio G, Nielsen GP, Jorda M.

Case Rep Endocrinol. 2017;2017:6734695. doi: 10.1155/2017/6734695. Epub 2017 Nov 26.

7.

Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer.

Klein Hesselink EN, Zafon C, Villalmanzo N, Iglesias C, van Hemel BM, Klein Hesselink MS, Montero-Conde C, Buj R, Mauricio D, Peinado MA, Puig-Domingo M, Riesco-Eizaguirre G, Reverter JL, Robledo M, Links TP, Jordà M.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):397-406. doi: 10.1210/jc.2017-01613.

PMID:
29165662
8.

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.

Samaranayake GJ, Troccoli CI, Huynh M, Lyles RDZ, Kage K, Win A, Lakshmanan V, Kwon D, Ban Y, Chen SX, Zarco ER, Jorda M, Burnstein KL, Rai P.

Nat Commun. 2017 Oct 31;8(1):1204. doi: 10.1038/s41467-017-01269-x.

9.

Review on the Processing and Properties of Polymer Nanocomposites and Nanocoatings and Their Applications in the Packaging, Automotive and Solar Energy Fields.

Müller K, Bugnicourt E, Latorre M, Jorda M, Echegoyen Sanz Y, Lagaron JM, Miesbauer O, Bianchin A, Hankin S, Bölz U, Pérez G, Jesdinszki M, Lindner M, Scheuerer Z, Castelló S, Schmid M.

Nanomaterials (Basel). 2017 Mar 31;7(4). pii: E74. doi: 10.3390/nano7040074. Review.

10.

The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells.

Jordà M, Díez-Villanueva A, Mallona I, Martín B, Lois S, Barrera V, Esteller M, Vavouri T, Peinado MA.

Genome Res. 2017 Jan;27(1):118-132. doi: 10.1101/gr.207522.116. Epub 2016 Dec 20.

11.

Adaptation to Stressors by Systemic Protein Amyloidogenesis.

Audas TE, Audas DE, Jacob MD, Ho JJ, Khacho M, Wang M, Perera JK, Gardiner C, Bennett CA, Head T, Kryvenko ON, Jorda M, Daunert S, Malhotra A, Trinkle-Mulcahy L, Gonzalgo ML, Lee S.

Dev Cell. 2016 Oct 24;39(2):155-168. doi: 10.1016/j.devcel.2016.09.002. Epub 2016 Oct 6.

12.

Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer.

Kryvenko ON, Williamson SR, Trpkov K, Gupta NS, Athanazio D, Selig MK, Smith PT, Magi-Galluzzi C, Jorda M.

Virchows Arch. 2017 Jan;470(1):47-54. doi: 10.1007/s00428-016-2033-7. Epub 2016 Oct 14.

PMID:
27743032
13.

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL, Alshalalfa M, Buerki C, Castillo R, Jorda M, Ashab HA, Kryvenko ON, Punnen S, Parekh DJ, Abramowitz MC, Gillies RJ, Davicioni E, Erho N, Ishkanian A.

Oncotarget. 2016 Aug 16;7(33):53362-53376. doi: 10.18632/oncotarget.10523.

14.

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Koru-Sengul T, Santander AM, Miao F, Sanchez LG, Jorda M, Glück S, Ince TA, Nadji M, Chen Z, Penichet ML, Cleary MP, Torroella-Kouri M.

Breast Cancer Res Treat. 2016 Jul;158(1):113-126. doi: 10.1007/s10549-016-3847-3. Epub 2016 Jun 9.

15.

Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.

Harding-Jackson N, Kryvenko ON, Whittington EE, Eastwood DC, Tjionas GA, Jorda M, Iczkowski KA.

J Urol. 2016 Oct;196(4):1076-81. doi: 10.1016/j.juro.2016.05.105. Epub 2016 Jun 2.

PMID:
27265220
16.

Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template Biopsy.

Kryvenko ON, Lyapichev K, Chinea FM, Prakash NS, Pollack A, Gonzalgo ML, Punnen S, Jorda M.

Am J Surg Pathol. 2016 Aug;40(8):1125-32. doi: 10.1097/PAS.0000000000000656.

17.

Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.

Buj R, Mallona I, Díez-Villanueva A, Barrera V, Mauricio D, Puig-Domingo M, Reverter JL, Matias-Guiu X, Azuara D, Ramírez JL, Alonso S, Rosell R, Capellà G, Perucho M, Robledo M, Peinado MA, Jordà M.

Oncotarget. 2016 Mar 1;7(9):10536-46. doi: 10.18632/oncotarget.7233.

18.

A knowledgebase of the human Alu repetitive elements.

Mallona I, Jordà M, Peinado MA.

J Biomed Inform. 2016 Apr;60:77-83. doi: 10.1016/j.jbi.2016.01.010. Epub 2016 Jan 28.

19.

Average Weight of Seminal Vesicles: An Adjustment Factor for Radical Prostatectomy Specimens Weighed With Seminal Vesicles.

Tjionas GA, Epstein JI, Williamson SR, Diaz M, Menon M, Peabody JO, Gupta NS, Parekh DJ, Cote RJ, Jorda M, Kryvenko ON.

Int J Surg Pathol. 2015 Dec;23(8):617-22. doi: 10.1177/1066896915600519. Epub 2015 Aug 25.

PMID:
26306700
20.

Overlapping DNA methylation dynamics in mouse intestinal cell differentiation and early stages of malignant progression.

Forn M, Díez-Villanueva A, Merlos-Suárez A, Muñoz M, Lois S, Carriò E, Jordà M, Bigas A, Batlle E, Peinado MA.

PLoS One. 2015 May 1;10(5):e0123263. doi: 10.1371/journal.pone.0123263. eCollection 2015.

21.

Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Lokeshwar SD, Ruiz-Cordero R, Hupe MC, Jorda M, Soloway MS.

World J Urol. 2015 Dec;33(12):1929-36. doi: 10.1007/s00345-015-1548-x. Epub 2015 Apr 2.

PMID:
25833661
22.

Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases.

Kryvenko ON, Rosenberg AE, Jorda M, Epstein JI.

Am J Surg Pathol. 2015 Sep;39(9):1219-25. doi: 10.1097/PAS.0000000000000426.

PMID:
25828386
23.

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance.

Sandler K, Patel M, Lynne C, Parekh DJ, Punnen S, Jorda M, Casillas J, Pollack A, Stoyanova R.

Front Oncol. 2015 Jan 26;5:4. doi: 10.3389/fonc.2015.00004. eCollection 2015.

24.

Diagnostic approach to eosinophilic renal neoplasms.

Kryvenko ON, Jorda M, Argani P, Epstein JI.

Arch Pathol Lab Med. 2014 Nov;138(11):1531-41. doi: 10.5858/arpa.2013-0653-RA. Review.

25.

Factors associated with diagnostic accuracy when performing a preablation renal biopsy.

Lorber G, Jorda M, Leveillee R.

J Endourol. 2014 Dec;28(12):1444-7. doi: 10.1089/end.2014.0222.

PMID:
25299890
26.

The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.

Salazar N, Muñoz D, Kallifatidis G, Singh RK, Jordà M, Lokeshwar BL.

Mol Cancer. 2014 Aug 28;13:198. doi: 10.1186/1476-4598-13-198.

27.

Factors Associated With Diagnostic Accuracy When Performing a Pre-Ablation Renal Biopsy.

Lorber G, Jorda M, Leveillee RJ.

J Endourol. 2014 Aug 8. [Epub ahead of print]

PMID:
25105972
28.

Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.

Lorber G, Glamore M, Doshi M, Jorda M, Morillo-Burgos G, Leveillee RJ.

Urol Oncol. 2014 Oct;32(7):1017-23. doi: 10.1016/j.urolonc.2014.03.005. Epub 2014 Jul 2.

PMID:
24996776
29.

Haemangiomas in kidneys with end-stage renal disease: a novel clinicopathological association.

Kryvenko ON, Haley SL, Smith SC, Shen SS, Paluru S, Gupta NS, Jorda M, Epstein JI, Amin MB, Truong LD.

Histopathology. 2014 Sep;65(3):309-18. doi: 10.1111/his.12394. Epub 2014 May 29.

PMID:
24548339
30.

DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.

Mancikova V, Buj R, Castelblanco E, Inglada-Pérez L, Diez A, de Cubas AA, Curras-Freixes M, Maravall FX, Mauricio D, Matias-Guiu X, Puig-Domingo M, Capel I, Bella MR, Lerma E, Castella E, Reverter JL, Peinado MÁ, Jorda M, Robledo M.

Int J Cancer. 2014 Aug 1;135(3):598-610. doi: 10.1002/ijc.28703. Epub 2014 Jan 13.

31.

Toxic effects of a modified montmorillonite clay on the human intestinal cell line Caco-2.

Maisanaba S, Gutiérrez-Praena D, Pichardo S, Moreno FJ, Jordá M, Cameán AM, Aucejo S, Jos A.

J Appl Toxicol. 2014 Jun;34(6):714-25. doi: 10.1002/jat.2945. Epub 2013 Oct 9.

PMID:
24122917
32.

Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells.

Forn M, Muñoz M, Tauriello DV, Merlos-Suárez A, Rodilla V, Bigas A, Batlle E, Jordà M, Peinado MA.

Mol Oncol. 2013 Dec;7(6):1129-41. doi: 10.1016/j.molonc.2013.08.008. Epub 2013 Aug 30.

33.

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Reynés G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jordá M, Martínez-Sales V.

PLoS One. 2013 Jul 29;8(7):e69034. doi: 10.1371/journal.pone.0069034. Print 2013.

34.

High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder.

Chapman-Fredricks JR, Cioffi-Lavina M, Accola MA, Rehrauer WM, Garcia-Buitrago MT, Gomez-Fernandez C, Ganjei-Azar P, Jordà M.

Arch Pathol Lab Med. 2013 Aug;137(8):1088-93. doi: 10.5858/arpa.2012-0122-OA.

PMID:
23899065
35.

Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.

Burton DG, Giribaldi MG, Munoz A, Halvorsen K, Patel A, Jorda M, Perez-Stable C, Rai P.

PLoS One. 2013 Jun 28;8(6):e68003. doi: 10.1371/journal.pone.0068003. Print 2013.

36.

In vitro toxicological assessment of clays for their use in food packaging applications.

Maisanaba S, Puerto M, Pichardo S, Jordá M, Moreno FJ, Aucejo S, Jos Á.

Food Chem Toxicol. 2013 Jul;57:266-75. doi: 10.1016/j.fct.2013.03.043. Epub 2013 Apr 8.

PMID:
23579166
37.

Inflammatory myofibroblastic tumor of the kidney.

Jenkins LC, Whittington E, Ciancio G, Jorda M.

J Urol. 2013 Jun;189(6):2310-1. doi: 10.1016/j.juro.2013.03.036. Epub 2013 Mar 15. No abstract available.

PMID:
23507397
38.

Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods.

Iremashvili V, Lokeshwar SD, Jorda M, Pelaez L, Soloway MS.

J Urol. 2013 Jul;190(1):84-90. doi: 10.1016/j.juro.2012.12.021. Epub 2012 Dec 14.

PMID:
23246479
39.

p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma.

Grimes R, Garcia-Buitrago MT, Jorda M, Ganjei-Azar P, Ferrell A, Gomez-Fernandez C.

Acta Cytol. 2013;57(1):33-7. doi: 10.1159/000342501. Epub 2012 Dec 6.

PMID:
23221169
40.

Epigenetics of host-pathogen interactions: the road ahead and the road behind.

Gómez-Díaz E, Jordà M, Peinado MA, Rivero A.

PLoS Pathog. 2012;8(11):e1003007. doi: 10.1371/journal.ppat.1003007. Epub 2012 Nov 29. Review.

41.

Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management.

Gorin MA, Garcia-Roig M, Garcia-Buitrago M, Parra-Herran C, Jorda M, Ciancio G.

World J Urol. 2013 Dec;31(6):1531-4. doi: 10.1007/s00345-012-0978-y. Epub 2012 Nov 28.

PMID:
23187761
42.

Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy.

Iremashvili V, Pelaez L, Jordá M, Manoharan M, Rosenberg DL, Soloway MS.

Urology. 2012 Nov;80(5):1063-9. doi: 10.1016/j.urology.2012.08.012.

PMID:
23107397
43.

Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.

Leveillee RJ, Castle SM, Gorbatiy V, Salas N, Narayanan G, Morillo-Burgos G, Jorda M, Faraday MM.

J Endourol. 2013 Apr;27(4):480-9. doi: 10.1089/end.2012.0305. Epub 2013 Mar 26.

PMID:
23098088
44.

Partial sampling of radical prostatectomy specimens: detection of positive margins and extraprostatic extension.

Iremashvili V, Lokeshwar SD, Soloway MS, Pelaez L, Umar SA, Manoharan M, Jordá M.

Am J Surg Pathol. 2013 Feb;37(2):219-25. doi: 10.1097/PAS.0b013e318268ccc1.

PMID:
23095506
45.

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.

Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):16-35. doi: 10.1016/j.eururo.2012.09.063. Epub 2012 Oct 5. Review.

PMID:
23083804
46.

Macrophages as independent prognostic factors in small T1 breast cancers.

Carrio R, Koru-Sengul T, Miao F, Glück S, Lopez O, Selman Y, Alvarez C, Milikowski C, Gomez C, Jorda M, Nadji M, Torroella-Kouri M.

Oncol Rep. 2013 Jan;29(1):141-8. doi: 10.3892/or.2012.2088. Epub 2012 Oct 17.

PMID:
23076599
47.

Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.

Reyes C, Jorda M, Gomez-Fernández C.

Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):283-6. doi: 10.1097/PAI.0b013e31826a277e. Review.

PMID:
22935826
48.

Salvage robot-assisted partial nephrectomy for the management of renal cell carcinoma following failed stereotactic radiotherapy.

Gorin MA, Gorbatiy V, Glenn C, Shirodkar SP, Castle SM, Jorda M, Leveillee RJ.

JSLS. 2012 Jan-Mar;16(1):159-62. doi: 10.4293/108680812X13291597716988.

49.

Pathological possibilities and pitfalls in detecting aggressive bladder cancer.

Mitra AP, Jordà M, Cote RJ.

Curr Opin Urol. 2012 Sep;22(5):397-404. doi: 10.1097/MOU.0b013e328356ade6. Review.

PMID:
22825461
50.

Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma.

Rojas CP, Castle SM, Llanos CA, Santos Cortes JA, Bird V, Rodriguez S, Reis IM, Zhao W, Gomez-Fernandez C, Leveillee RJ, Jorda M.

Urol Oncol. 2013 Nov;31(8):1696-700. doi: 10.1016/j.urolonc.2012.05.010. Epub 2012 Jul 21.

PMID:
22819696

Supplemental Content

Support Center